speb/financial-data huggingface dataset:
Financial ratios for CERA.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 86.60088588413568
Shares outstanding: 12894976
Market cap (USD): 1116716345.0546684
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CERA.NS — annual report dated 2025-03-31
Total revenue: 219274257.65723637
Gross profit: 105085749.35702595
Operating income: 29912450.3156418
Net income: 28815092.354454055
Capital expenditures: 3057236.3806406357
Operating cash flow: 13514192.190787934
Depreciation & amortization: 4502560.205751695
Net tangible assets: 157789572.12999764
Owner earnings: 30260416.179565113
Return on net tangible assets (%): 19.17770342556893
Capex to operating income (%): 10.220614989344243
Buffett classification: The Great
Stock price: 64.43855759131753
P/E ratio: 28.836751359091757
Shares outstanding: 12894976
Book value: 157861024.08230066
P/B ratio: 5.263703681419495
Market cap (USD): 830933653.6146574
Debt to equity: 0.04698361127748857
Current ratio: 3.799419373999792
Quick ratio: 2.705707728222617
Effective tax rate (%): 19.473890890463142
Interest coverage ratio: 36.779999425023
COGS to revenue (%): 52.07565608485919
R&D to revenue (%): 0.09705854754989145
SG&A to revenue (%): 15.329828456147984
Free cash flow (dilution-adjusted): 9882382.511105914
Buyback yield (%): 2.3166078117774576
Retained earnings: 87267290.15665185
Inventory turnover: 2.406904994415002
Receivables turnover: 6.999713767627828
Capitalized R&D asset: 391822.0167119944
ROCI (R&D-adjusted, %): 17.38143332170847
Rosenberg metric: -35.868646956825984
FCF margin (%): 4.506859408254748
Revenue growth (%): -2.0337537377049006
Rule of 40 score: 2.473105670549847
Financial ratios for CERA.NS — quarterly report dated 2025-03-31
Total revenue: 67567640.86976853
Gross profit: 34171206.45312134
Operating income: 11153027.823240587
Net income: 10005003.507131167
Capital expenditures: 0
Depreciation & amortization: 1190016.3666121112
Net tangible assets: 157789572.12999764
Owner earnings: 11195019.873743277
Return on net tangible assets (%): 7.0949047662795275
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 64.43855759131753
P/E ratio: 20.762952582235506
Shares outstanding: 12894976
Book value: 157861024.08230066
P/B ratio: 5.263703681419495
Market cap (USD): 830933653.6146574
Debt to equity: 0.04698361127748857
Current ratio: 3.799419373999792
Quick ratio: 2.705707728222617
Effective tax rate (%): 20.80623609666542
Interest coverage ratio: 59.71271202353383
COGS to revenue (%): 49.42666931499985
Buyback yield (%): 0
Retained earnings: 87267290.15665185
Inventory turnover: 0.7039416311644123
Receivables turnover: 2.156906839386321
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.490589893067831
Rule of 40 score: 0
Financial ratios for CERA.NS — quarterly report dated 2025-06-30
Total revenue: 49401743.50573368
Gross profit: 26194792.885560498
Operating income: 5333828.691785631
Net income: 5505604.961385444
Capital expenditures: 0
Depreciation & amortization: 1112871.518839223
Owner earnings: 6618476.480224667
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 78.77685466885093
P/E ratio: 65.49231465498215
Shares outstanding: 12894976
Market cap (USD): 1015825650.3103207
Effective tax rate (%): 24.347438795756464
Interest coverage ratio: 29.8688814625516
COGS to revenue (%): 46.97597488129084
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -26.885498931431133
Rule of 40 score: -26.885498931431133
Financial ratios for CERA.NS — quarterly report dated 2025-09-30
Total revenue: 55007091.31905299
Gross profit: 27911386.69673055
Operating income: 6461037.204058625
Net income: 6386426.155580608
Capital expenditures: 0
Depreciation & amortization: 1108049.6054114995
Net tangible assets: 154458083.42728296
Owner earnings: 7494475.760992108
Return on net tangible assets (%): 4.852109772888913
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 68.68275084554678
P/E ratio: 40.44668325968909
Shares outstanding: 12894976
Book value: 154520090.19165727
P/B ratio: 5.731697558995623
Market cap (USD): 885662423.7673054
Debt to equity: 0.0435222500739096
Current ratio: 4.354778081088548
Quick ratio: 3.0024888131392355
Effective tax rate (%): 21.57754184669525
Interest coverage ratio: 34.95114960053669
COGS to revenue (%): 49.25856643675541
Buyback yield (%): 0
Inventory turnover: 0.5547853630543665
Receivables turnover: 2.334849980643127
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.837700596621034
Revenue growth (%): 11.346457463932893
Rule of 40 score: 11.346457463932893
Financial ratios for CERA.NS — quarterly report dated 2025-12-31
Total revenue: 55583702.796034314
Gross profit: 27857870.11250975
Operating income: 4596134.566113401
Net income: 2636526.679291523
Capital expenditures: 0
Depreciation & amortization: 1090965.8014927036
Owner earnings: 3727492.4807842267
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 57.6555642196725
P/E ratio: 30.304084583775566
Shares outstanding: 12894976
Market cap (USD): 743467116.8791356
Effective tax rate (%): 26.57958084649651
Interest coverage ratio: 20.93009689037691
COGS to revenue (%): 49.88122649055093
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.0482493495917755
Rule of 40 score: 1.0482493495917755
Financial ratios for CIFR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.63
Shares outstanding: 409049197
Market cap (USD): 1893897782.11
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIFR — annual report dated 2022-12-31
Total revenue: 3037000
Gross profit: 2289000
Operating income: -72467000
Net income: -39053000
Capital expenditures: 227322000
Operating cash flow: -20915000
Depreciation & amortization: 5150000
Net tangible assets: 342296000
Owner earnings: -261225000
Return on net tangible assets (%): -76.31552808095917
Buffett classification: The Gruesome
Stock price: 0.56
Shares outstanding: 409049197
Book value: 342892000
P/B ratio: 0.6680457704466713
Market cap (USD): 229067550.32000002
Debt to equity: 0.060249291322048926
Current ratio: 1.1837276198978326
Quick ratio: 1.0279224321777514
Interest coverage ratio: -528.956204379562
COGS to revenue (%): 24.62956865327626
SG&A to revenue (%): 2332.43332235759
Free cash flow (dilution-adjusted): -290337000
Buyback yield (%): 1.3489470663493668
Retained earnings: -111209000
Inventory turnover: 0.11905140856278848
Receivables turnover: 2.5308333333333333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.164218259519696
FCF margin (%): -9559.993414553835
Rule of 40 score: -9559.993414553835
Financial ratios for CIFR — annual report dated 2023-12-31
Total revenue: 126842000
Gross profit: 19134000
Operating income: -55459000
Net income: -25777000
Capital expenditures: 54386000
Operating cash flow: -94241000
Depreciation & amortization: 59915000
Net tangible assets: 483227000
Owner earnings: -20248000
Return on net tangible assets (%): -4.190163215217693
Buffett classification: The Gruesome
Stock price: 4.13
Shares outstanding: 409049197
Book value: 491336000
P/B ratio: 3.4383256745078725
Market cap (USD): 1689373183.61
Debt to equity: 0.04473110050963088
Current ratio: 4.601485514751576
Quick ratio: 3.6256029355191903
Interest coverage ratio: -27.74337168584292
COGS to revenue (%): 84.91509121584333
SG&A to revenue (%): 21.913877106951958
Free cash flow (dilution-adjusted): -187731000
Buyback yield (%): 0.23097324130964755
Retained earnings: -136777000
Inventory turnover: 3.2660561586512222
Receivables turnover: 146.29988465974625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.417887681649459
FCF margin (%): -148.00381577080145
Revenue growth (%): 4076.5558116562397
Rule of 40 score: 3928.5519958854384
Financial ratios for CIFR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.87
Shares outstanding: 409049197
Market cap (USD): 1583020392.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIFR — annual report dated 2024-12-31
Total revenue: 151270000
Gross profit: 28110000
Operating income: -98255000
Net income: -44635000
Capital expenditures: 302453000
Operating cash flow: -87511000
Depreciation & amortization: 103697000
Net tangible assets: 673072000
Owner earnings: -243391000
Return on net tangible assets (%): -36.161213064872705
Buffett classification: The Gruesome
Stock price: 4.64
Shares outstanding: 409049197
Book value: 681953000
P/B ratio: 2.783165810664371
Market cap (USD): 1897988274.08
Debt to equity: 0.08273150788983992
Current ratio: 1.2764270212023252
Quick ratio: 0.5733430466390445
Interest coverage ratio: -57.526346604215455
COGS to revenue (%): 81.41733324519072
SG&A to revenue (%): 21.58722813512263
Free cash flow (dilution-adjusted): -433519000
Buyback yield (%): 1.4563314419525721
Retained earnings: -181412000
Inventory turnover: 1.329289484193371
Receivables turnover: 4.330165454857732
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.57735867828894
FCF margin (%): -286.5862365307067
Revenue growth (%): 19.258605193863232
Rule of 40 score: -267.32763133684347
Financial ratios for CIFR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.64
Shares outstanding: 409049197
Market cap (USD): 1897988274.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIFR — quarterly report dated 2025-03-31
Total revenue: 48959000
Gross profit: 19762000
Operating income: -32144000
Net income: -38975000
Capital expenditures: 99675000
Operating cash flow: -47238000
Depreciation & amortization: 43836000
Net tangible assets: 725752000
Owner earnings: -94814000
Return on net tangible assets (%): -13.06424233071352
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 409049197
Book value: 734795000
P/B ratio: 1.2803750067705957
Market cap (USD): 940813153.0999999
Debt to equity: 0.07945481392769412
Current ratio: 1.113996583562177
Quick ratio: 0.7390245133017637
Interest coverage ratio: -41.369369369369366
COGS to revenue (%): 59.6356134724974
SG&A to revenue (%): 18.282644661859923
Free cash flow (dilution-adjusted): -156397000
Buyback yield (%): 0.1215969394380271
Retained earnings: -220387000
Inventory turnover: 0.561221743810549
Receivables turnover: 1.459067203099389
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.147339981497992
FCF margin (%): -319.44484160215694
Rule of 40 score: -319.44484160215694
Financial ratios for CIFR — quarterly report dated 2025-06-30
Total revenue: 43565000
Gross profit: 12576000
Operating income: -41566000
Net income: -45781000
Capital expenditures: 118570000
Operating cash flow: -56217000
Depreciation & amortization: 44483000
Net tangible assets: 739675000
Owner earnings: -119868000
Return on net tangible assets (%): -16.20549565687633
Buffett classification: The Gruesome
Stock price: 4.78
Shares outstanding: 409049197
Book value: 748904000
P/B ratio: 2.610822163668508
Market cap (USD): 1955255161.66
Debt to equity: 0.252753356905558
Current ratio: 4.183579019540624
Quick ratio: 2.0487944234944577
Interest coverage ratio: -36.557607739665784
COGS to revenue (%): 71.13279008378285
SG&A to revenue (%): 20.837828532078504
Free cash flow (dilution-adjusted): -185663000
Buyback yield (%): 0.16228060982619483
Retained earnings: -266168000
Inventory turnover: 0.27646780683207095
Receivables turnover: 23.884320175438596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.3017718961804
FCF margin (%): -426.17468151038673
Revenue growth (%): -11.017381890969995
Rule of 40 score: -437.19206340135673
Financial ratios for CIFR — quarterly report dated 2025-09-30
Total revenue: 71707000
Gross profit: 30529000
Operating income: -34751000
Net income: -3283000
Capital expenditures: 44724000
Operating cash flow: -50051000
Depreciation & amortization: 59988000
Net tangible assets: 773770000
Owner earnings: 11981000
Buffett classification: The Gruesome
Stock price: 12.59
Shares outstanding: 409049197
Book value: 783195000
P/B ratio: 6.575539157208613
Market cap (USD): 5149929390.23
Debt to equity: 1.3329707161051845
Current ratio: 2.4892353664289333
Quick ratio: 2.19058758748402
Interest coverage ratio: -27.022550544323483
COGS to revenue (%): 57.42535596245833
SG&A to revenue (%): 11.389404102807257
Free cash flow (dilution-adjusted): -103388000
Buyback yield (%): 0.05763185813053345
Retained earnings: -269451000
Inventory turnover: 0.2417925697139804
Receivables turnover: 71.42131474103586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5304637193646313
FCF margin (%): -144.18118175352475
Revenue growth (%): 64.59772753357052
Rule of 40 score: -79.58345421995423
Financial ratios for CIFR — quarterly report dated 2025-12-31
Total revenue: 59711000
Gross profit: 730000
Operating income: -228943000
Net income: -734205000
Capital expenditures: 229826000
Operating cash flow: -54432000
Depreciation & amortization: 52911000
Net tangible assets: 728147000
Owner earnings: -911120000
Return on net tangible assets (%): -125.12857980600072
Buffett classification: The Gruesome
Stock price: 14.76
Shares outstanding: 409049197
Book value: 835854000
P/B ratio: 7.223230549497879
Market cap (USD): 6037566147.72
Debt to equity: 3.3104441684791843
Current ratio: 3.794834859406269
Quick ratio: 3.6154539381550657
Interest coverage ratio: -6.863005485775952
COGS to revenue (%): 98.77744469193281
SG&A to revenue (%): 17.05883338078411
Free cash flow (dilution-adjusted): -309514000
Buyback yield (%): 1.363132063258295
Retained earnings: -1003656000
Inventory turnover: 0.4703429027113238
Receivables turnover: 62.32881002087683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.372206699051473
FCF margin (%): -518.3534022206964
Revenue growth (%): -16.72918961886566
Rule of 40 score: -535.082591839562
Financial ratios for CIFR — annual report dated 2025-12-31
Total revenue: 223942000
Gross profit: 63597000
Operating income: -337404000
Net income: -822244000
Capital expenditures: 492795000
Operating cash flow: -207938000
Depreciation & amortization: 200619000
Net tangible assets: 728147000
Owner earnings: -1114420000
Return on net tangible assets (%): -153.04876625186947
Buffett classification: The Gruesome
Stock price: 14.76
Shares outstanding: 409049197
Book value: 835854000
P/B ratio: 7.223230549497879
Market cap (USD): 6037566147.72
Debt to equity: 3.3104441684791843
Current ratio: 3.794834859406269
Quick ratio: 3.6154539381550657
Interest coverage ratio: -9.229027052162259
COGS to revenue (%): 71.60112886372364
SG&A to revenue (%): 16.246170883532344
Free cash flow (dilution-adjusted): -754962000
Buyback yield (%): 1.4837932671566751
Retained earnings: -1003656000
Inventory turnover: 1.2786682615629985
Receivables turnover: 233.75991649269312
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.39101885223293
FCF margin (%): -337.1238981522001
Revenue growth (%): 48.041250743703316
Rule of 40 score: -289.0826474084968
Financial ratios for CNTB — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 627000
Buffett classification: The Gruesome
Stock price: 5.15
Shares outstanding: 62963853
Market cap (USD): 324263842.95000005
Buyback yield (%): 0.17454921734436932
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTB — annual report dated 2022-12-31
Total revenue: 0
Operating income: -116507000
Net income: -118091000
Capital expenditures: 4405000
Operating cash flow: -101520000
Depreciation & amortization: 1031000
Net tangible assets: 154327000
Owner earnings: -121465000
Return on net tangible assets (%): -78.70625360435957
Buffett classification: The Gruesome
Stock price: 0.87
Shares outstanding: 62963853
Book value: 157492000
P/B ratio: 0.347817997803063
Market cap (USD): 54778552.11
Debt to equity: 0.002736646940796993
Current ratio: 9.970494111623143
Quick ratio: 9.970494111623143
Interest coverage ratio: -5547.952380952381
Free cash flow (dilution-adjusted): -112832000
Buyback yield (%): 0
Retained earnings: -479844000
Receivables turnover: 0
Capitalized R&D asset: 96630000
ROCI (R&D-adjusted, %): -20.42475266548767
Rule of 40 score: 0
Financial ratios for CNTB — annual report dated 2023-12-31
Total revenue: 0
Operating income: -69056000
Net income: -62106000
Capital expenditures: 2862000
Operating cash flow: -47741000
Depreciation & amortization: 979000
Net tangible assets: 101435000
Owner earnings: -63989000
Return on net tangible assets (%): -63.08374821314142
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 62963853
Book value: 101497000
P/B ratio: 0.7320151978876223
Market cap (USD): 74297346.53999999
Debt to equity: 0.004581416199493581
Current ratio: 4.845332700747242
Quick ratio: 4.845332700747242
Interest coverage ratio: -3002.4347826086955
Free cash flow (dilution-adjusted): -53218000
Buyback yield (%): 0
Retained earnings: -329727000
Receivables turnover: 0
Capitalized R&D asset: 117744100
ROCI (R&D-adjusted, %): -29.992495583251188
Rule of 40 score: 0
Financial ratios for CNTB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.44
Shares outstanding: 62963853
Market cap (USD): 90667948.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTB — annual report dated 2024-12-31
Total revenue: 26033
Operating income: -22452000
Net income: -15628000
Capital expenditures: 750000
Operating cash flow: -23612000
Depreciation & amortization: 660000
Net tangible assets: 92113000
Owner earnings: -15718000
Return on net tangible assets (%): -17.063823781659483
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 62963853
Book value: 92166000
P/B ratio: 0.9427567339365927
Market cap (USD): 86890117.14
Debt to equity: 0.0019312978755723369
Current ratio: 11.458402268967147
Quick ratio: 11.458402268967147
COGS to revenue (%): 0
R&D to revenue (%): 112380.44021050204
SG&A to revenue (%): 73863.94191987094
Free cash flow (dilution-adjusted): -31090000
Buyback yield (%): 0
Retained earnings: -345355000
Receivables turnover: 0.024769743101807802
Capitalized R&D asset: 96655240
ROCI (R&D-adjusted, %): -27.879513831494133
FCF margin (%): -119425.34475473437
Rule of 40 score: -119425.34475473437
Financial ratios for CNTB — quarterly report dated 2024-12-31
Capital expenditures: 313000
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 62963853
Market cap (USD): 86890117.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTB — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -11447000
Net income: -10272000
Capital expenditures: 79000
Operating cash flow: -9959000
Depreciation & amortization: 173000
Net tangible assets: 82849000
Owner earnings: -10178000
Return on net tangible assets (%): -12.28500042245531
Buffett classification: The Gruesome
Stock price: 0.55
Shares outstanding: 62963853
Book value: 82899000
P/B ratio: 0.41773868382007023
Market cap (USD): 34630119.150000006
Debt to equity: 0.011339099385999831
Current ratio: 10.245767659077641
Quick ratio: 10.245767659077641
Free cash flow (dilution-adjusted): -10982000
Buyback yield (%): 0
Retained earnings: -355627000
Receivables turnover: 0
Capitalized R&D asset: 6633000
ROCI (R&D-adjusted, %): -7.740790938040616
Rule of 40 score: 0
Financial ratios for CNTB — quarterly report dated 2025-06-30
Total revenue: 48000
Operating income: -13424000
Net income: -12899000
Capital expenditures: 303000
Operating cash flow: -12591000
Depreciation & amortization: 171000
Net tangible assets: 71294000
Owner earnings: -13031000
Return on net tangible assets (%): -18.277835441972677
Buffett classification: The Gruesome
Stock price: 0.98
Shares outstanding: 62963853
Book value: 71342000
P/B ratio: 0.8649123369123377
Market cap (USD): 61704575.94
Debt to equity: 0.01219478007344902
Current ratio: 7.239176985383112
Quick ratio: 7.239176985383112
COGS to revenue (%): 0
R&D to revenue (%): 18277.083333333336
SG&A to revenue (%): 9789.583333333332
Free cash flow (dilution-adjusted): -13845000
Buyback yield (%): 0
Retained earnings: -368526000
Receivables turnover: 0.24870466321243523
Capitalized R&D asset: 13217110
ROCI (R&D-adjusted, %): -11.48615708566864
FCF margin (%): -28843.75
Rule of 40 score: -28843.75
Financial ratios for CNTB — quarterly report dated 2025-09-30
Total revenue: 16000
Operating income: -17677000
Net income: -17200000
Capital expenditures: 34000
Operating cash flow: -17406000
Depreciation & amortization: 179000
Net tangible assets: 55324000
Owner earnings: -17055000
Return on net tangible assets (%): -30.827488974043817
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 62963853
Book value: 55371000
P/B ratio: 1.7170616031857833
Market cap (USD): 95075418.03
Debt to equity: 0.014104856332737354
Current ratio: 5.4779907237245125
Quick ratio: 5.4779907237245125
COGS to revenue (%): 0
R&D to revenue (%): 69437.5
SG&A to revenue (%): 41143.75
Free cash flow (dilution-adjusted): -18356000
Buyback yield (%): 0
Retained earnings: -385726000
Receivables turnover: 0.09195402298850575
Capitalized R&D asset: 19176800
ROCI (R&D-adjusted, %): -20.510587913677746
FCF margin (%): -114725
Revenue growth (%): -66.66666666666666
Rule of 40 score: -114791.66666666667
Financial ratios for CNTB — annual report dated 2025-12-31
Total revenue: 64000
Operating income: -58074000
Net income: -55480000
Capital expenditures: 432000
Operating cash flow: -51206000
Depreciation & amortization: 704000
Net tangible assets: 41935000
Owner earnings: -55208000
Return on net tangible assets (%): -131.6513652080601
Buffett classification: The Gruesome
Stock price: 2.82
Shares outstanding: 62963853
Book value: 41980000
P/B ratio: 4.229587076226775
Market cap (USD): 177558065.45999998
Debt to equity: 0.01643639828489757
Current ratio: 3.7412032615881876
Quick ratio: 3.7412032615881876
COGS to revenue (%): 0
R&D to revenue (%): 59059.375
SG&A to revenue (%): 31781.25
Free cash flow (dilution-adjusted): -55366000
Buyback yield (%): 0
Retained earnings: -400835000
Receivables turnover: 0.39751552795031053
Capitalized R&D asset: 74890180
ROCI (R&D-adjusted, %): -51.37924720841715
FCF margin (%): -86509.375
Revenue growth (%): 145.84181615641685
Rule of 40 score: -86363.53318384358
Financial ratios for CNTB — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -15526000
Net income: -15109000
Capital expenditures: 16000
Operating cash flow: -11250000
Depreciation & amortization: 181000
Net tangible assets: 41935000
Owner earnings: -14944000
Return on net tangible assets (%): -35.63610349350185
Buffett classification: The Gruesome
Stock price: 2.82
Shares outstanding: 62963853
Book value: 41980000
P/B ratio: 4.229587076226775
Market cap (USD): 177558065.45999998
Debt to equity: 0.01643639828489757
Current ratio: 3.7412032615881876
Quick ratio: 3.7412032615881876
Free cash flow (dilution-adjusted): -12183000
Buyback yield (%): 0
Retained earnings: -400835000
Receivables turnover: 0
Capitalized R&D asset: 21620790
ROCI (R&D-adjusted, %): -22.833483581681342
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for COST — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 432.34
Shares outstanding: 443478804
Market cap (USD): 191733626121.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COST — annual report dated 2022-08-31
Total revenue: 226954000000
Gross profit: 27572000000
Operating income: 7793000000
Net income: 5915000000
Capital expenditures: 3891000000
Operating cash flow: 7392000000
Depreciation & amortization: 1900000000
Net tangible assets: 20642000000
Owner earnings: 3924000000
Return on net tangible assets (%): 19.009785873461873
Capex to operating income (%): 49.929423841909404
Buffett classification: The Good
Stock price: 498.79
P/E ratio: 37.39692183383939
Shares outstanding: 443478804
Book value: 20647000000
P/B ratio: 10.713556092757303
Market cap (USD): 221202792647.16
Debt to equity: 0.4377875720443648
Current ratio: 1.0218138633664604
Quick ratio: 0.4621851365710357
Effective tax rate (%): 24.553571428571427
Interest coverage ratio: 49.322784810126585
COGS to revenue (%): 87.85128263877262
SG&A to revenue (%): 8.714981890603383
Free cash flow (dilution-adjusted): 2777000000
Buyback yield (%): 0.19846042391528382
Retained earnings: 15585000000
Inventory turnover: 11.13430502038309
Receivables turnover: 101.2735385988398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.22593882118876
FCF margin (%): 1.223595970989716
Rule of 40 score: 1.223595970989716
Financial ratios for COST — annual report dated 2023-08-31
Total revenue: 242290000000
Gross profit: 29704000000
Operating income: 8114000000
Net income: 6292000000
Capital expenditures: 4323000000
Operating cash flow: 11068000000
Depreciation & amortization: 2077000000
Net tangible assets: 25058000000
Owner earnings: 4046000000
Return on net tangible assets (%): 16.14654002713704
Capex to operating income (%): 53.278284446635446
Buffett classification: The Good
Stock price: 528.71
P/E ratio: 37.26504743528926
Shares outstanding: 443478804
Book value: 25058000000
P/B ratio: 9.357158530722325
Market cap (USD): 234471678462.84003
Debt to equity: 0.354537473062495
Current ratio: 1.0683679242473871
Quick ratio: 0.5725515886013757
Effective tax rate (%): 25.863084717803698
Interest coverage ratio: 50.7125
COGS to revenue (%): 87.74031119732551
SG&A to revenue (%): 8.910809360683478
Free cash flow (dilution-adjusted): 5971000000
Buyback yield (%): 0.2883077412298795
Retained earnings: 19521000000
Inventory turnover: 12.767161131463576
Receivables turnover: 106.03501094091904
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.91378385247522
FCF margin (%): 2.464402162697594
Revenue growth (%): 6.757316460604351
Rule of 40 score: 9.221718623301946
Financial ratios for COST — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 884.08
Shares outstanding: 443478804
Market cap (USD): 392070741040.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COST — annual report dated 2024-08-31
Total revenue: 254453000000
Gross profit: 32095000000
Operating income: 9285000000
Net income: 7367000000
Capital expenditures: 4710000000
Operating cash flow: 11339000000
Depreciation & amortization: 2237000000
Net tangible assets: 23622000000
Owner earnings: 4894000000
Return on net tangible assets (%): 20.717974769282872
Capex to operating income (%): 50.72697899838449
Buffett classification: The Good
Stock price: 884.08
P/E ratio: 53.21986440074929
Shares outstanding: 443478804
Book value: 23622000000
P/B ratio: 16.597694566096013
Market cap (USD): 392070741040.32
Debt to equity: 0.3458216916433833
Current ratio: 0.965655312429506
Quick ratio: 0.4398545003383713
Effective tax rate (%): 24.363449691991786
Interest coverage ratio: 54.94082840236686
COGS to revenue (%): 87.38666865786608
SG&A to revenue (%): 8.964327400345054
Free cash flow (dilution-adjusted): 5811000000
Buyback yield (%): 0.1785392090576871
Retained earnings: 17619000000
Inventory turnover: 11.924599131227543
Receivables turnover: 93.51451672179346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.017196729420668
FCF margin (%): 2.2837223377205222
Revenue growth (%): 5.020017334599034
Rule of 40 score: 7.303739672319557
Financial ratios for COST — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 964.12
Shares outstanding: 443478804
Market cap (USD): 427566784512.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COST — quarterly report dated 2025-02-28
Total revenue: 63723000000
Gross profit: 7979000000
Operating income: 2316000000
Net income: 1788000000
Capital expenditures: 1137000000
Operating cash flow: 2748000000
Depreciation & amortization: 552000000
Net tangible assets: 25577000000
Owner earnings: 1203000000
Return on net tangible assets (%): 4.703444500918795
Capex to operating income (%): 49.09326424870466
Buffett classification: The Good
Stock price: 1041.38
P/E ratio: 64.57353983634229
Shares outstanding: 443478804
Book value: 25577000000
P/B ratio: 18.056455288326234
Market cap (USD): 461829956909.52
Debt to equity: 0.3143058216366267
Current ratio: 0.9972431687342901
Quick ratio: 0.4903646044487689
Effective tax rate (%): 26.176713459950452
Interest coverage ratio: 64.33333333333333
COGS to revenue (%): 87.47861839524191
SG&A to revenue (%): 8.886901118905262
Free cash flow (dilution-adjusted): 1460000000
Buyback yield (%): 0.0443886319917014
Retained earnings: 19770000000
Inventory turnover: 2.97237922576517
Receivables turnover: 20.82450980392157
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.393374741200828
FCF margin (%): 2.291166454812234
Rule of 40 score: 2.291166454812234
Financial ratios for COST — quarterly report dated 2025-05-31
Total revenue: 63205000000
Gross profit: 8209000000
Operating income: 2530000000
Net income: 1903000000
Capital expenditures: 1131000000
Operating cash flow: 3460000000
Depreciation & amortization: 552000000
Net tangible assets: 27125000000
Owner earnings: 1324000000
Return on net tangible assets (%): 4.881105990783411
Capex to operating income (%): 44.70355731225296
Buffett classification: The Good
Stock price: 1034.36
P/E ratio: 124.27979834880517
Shares outstanding: 443478804
Book value: 27125000000
P/B ratio: 16.91121606287336
Market cap (USD): 458716735705.43994
Debt to equity: 0.30156682027649767
Current ratio: 1.0152212671971048
Quick ratio: 0.5201043135793928
Effective tax rate (%): 26.24031007751938
Interest coverage ratio: 72.28571428571429
COGS to revenue (%): 87.01210347282652
SG&A to revenue (%): 8.985048651214303
Free cash flow (dilution-adjusted): 2223000000
Buyback yield (%): 0.04599788574870994
Retained earnings: 20890000000
Inventory turnover: 2.9558207029990324
Receivables turnover: 21.984347826086957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.6749333825818535
FCF margin (%): 3.517126809587849
Revenue growth (%): -0.8128933038306421
Rule of 40 score: 2.704233505757207
Financial ratios for COST — annual report dated 2025-08-31
Total revenue: 275235000000
Gross profit: 35349000000
Operating income: 10383000000
Net income: 8099000000
Capital expenditures: 5498000000
Operating cash flow: 13335000000
Depreciation & amortization: 2426000000
Net tangible assets: 29164000000
Owner earnings: 5027000000
Return on net tangible assets (%): 17.237004526128104
Capex to operating income (%): 52.95194067225272
Buffett classification: The Good
Stock price: 939.34
P/E ratio: 51.435656222911476
Shares outstanding: 443478804
Book value: 29164000000
P/B ratio: 14.28395898194212
Market cap (USD): 416577379749.36
Debt to equity: 0.2802427650528048
Current ratio: 1.0342783227336423
Quick ratio: 0.5460817074485286
Effective tax rate (%): 25.134035866149013
Interest coverage ratio: 67.42207792207792
COGS to revenue (%): 87.15679328573765
SG&A to revenue (%): 9.070794048722002
Free cash flow (dilution-adjusted): 6977000000
Buyback yield (%): 0.21676645057955463
Retained earnings: 22650000000
Inventory turnover: 13.241664826672555
Receivables turnover: 85.93037777083984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.963341751894177
FCF margin (%): 2.534924700710302
Revenue growth (%): 8.167323631476146
Rule of 40 score: 10.702248332186448
Financial ratios for COST — quarterly report dated 2025-08-31
Total revenue: 86156000000
Gross profit: 11119000000
Operating income: 3341000000
Net income: 2610000000
Capital expenditures: 1966000000
Operating cash flow: 3867000000
Depreciation & amortization: 774000000
Net tangible assets: 29164000000
Owner earnings: 1418000000
Return on net tangible assets (%): 4.862158825949801
Capex to operating income (%): 58.84465728823706
Buffett classification: The Good
Stock price: 939.34
P/E ratio: 66.11289949997779
Shares outstanding: 443478804
Book value: 29164000000
P/B ratio: 14.28395898194212
Market cap (USD): 416577379749.36
Debt to equity: 0.2802427650528048
Current ratio: 1.0342783227336423
Quick ratio: 0.5460817074485286
Effective tax rate (%): 25.64102564102564
Interest coverage ratio: 72.6304347826087
COGS to revenue (%): 87.0943404986304
SG&A to revenue (%): 9.027810019035238
Free cash flow (dilution-adjusted): 1761000000
Buyback yield (%): 0.06721440328048206
Retained earnings: 22650000000
Inventory turnover: 4.142029145506735
Receivables turnover: 26.898532625663442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.354379735440475
FCF margin (%): 2.043966757973908
Revenue growth (%): 36.31200063286133
Rule of 40 score: 38.35596739083523
Financial ratios for COST — quarterly report dated 2025-11-30
Total revenue: 67307000000
Gross profit: 8797000000
Operating income: 2463000000
Net income: 2001000000
Capital expenditures: 1526000000
Operating cash flow: 4688000000
Depreciation & amortization: 597000000
Net tangible assets: 30303000000
Owner earnings: 1072000000
Return on net tangible assets (%): 3.5376035376035375
Capex to operating income (%): 61.956963053187174
Buffett classification: The Good
Stock price: 911.02
P/E ratio: 48.66514815948928
Shares outstanding: 443478804
Book value: 30303000000
P/B ratio: 13.332609313271952
Market cap (USD): 404018060020.08
Debt to equity: 0.26736626736626734
Current ratio: 1.0384164573615595
Quick ratio: 0.5327113981581151
Effective tax rate (%): 22.531939605110338
Interest coverage ratio: 70.37142857142857
COGS to revenue (%): 86.93003699466622
SG&A to revenue (%): 9.410611080571114
Free cash flow (dilution-adjusted): 2676000000
Buyback yield (%): 0.0519778744518408
Retained earnings: 23869000000
Inventory turnover: 2.767607965564543
Receivables turnover: 20.831631073970907
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.009515676467
FCF margin (%): 3.975812322641033
Revenue growth (%): -21.877756627512884
Rule of 40 score: -17.90194430487185
Financial ratios for CRW.L — annual report dated 2021-06-30
Total revenue: 104969444.44444445
Gross profit: 97506944.44444445
Operating income: 27463888.888888888
Net income: 17923611.111111112
Capital expenditures: 220833.33333333334
Operating cash flow: 32690277.77777778
Depreciation & amortization: 7281944.444444445
Net tangible assets: 301623611.1111111
Owner earnings: 24984722.222222224
Return on net tangible assets (%): 8.28341061569561
Capex to operating income (%): 0.8040861737635279
Buffett classification: The Great
Stock price: 0.27319444444444446
P/E ratio: 0.5218478893142193
Shares outstanding: 34237148
Book value: 361498611.1111111
P/B ratio: 0.02587395453186773
Market cap (USD): 9353398.627222223
Debt to equity: 0.0084563103439002
Current ratio: 5.1620554959622735
Quick ratio: 5.1620554959622735
Effective tax rate (%): 1.974933535890619
Interest coverage ratio: 260.1842105263158
COGS to revenue (%): 7.109211675355262
R&D to revenue (%): 19.25031093704517
SG&A to revenue (%): 21.06433088994152
Free cash flow (dilution-adjusted): 15375000
Buyback yield (%): 6.266290302278869
Retained earnings: 65038888.88888889
Receivables turnover: 5.329901269393512
Capitalized R&D asset: 20206944.444444444
ROCI (R&D-adjusted, %): 10.65018910650189
FCF margin (%): 14.647119532138984
Rule of 40 score: 14.647119532138984
Financial ratios for CRW.L — annual report dated 2022-06-30
Total revenue: 201882926.8292683
Gross profit: 173617073.17073172
Operating income: 22674390.24390244
Net income: 11474390.24390244
Capital expenditures: 430487.80487804883
Operating cash flow: 32882926.829268295
Depreciation & amortization: 35857317.07317074
Net tangible assets: -162074390.24390244
Owner earnings: 46901219.512195125
Return on net tangible assets (%): -28.938081730009557
Capex to operating income (%): 1.8985639756897759
Buffett classification: The Great
Stock price: 0.21012195121951222
P/E ratio: 0.6269593581039431
Shares outstanding: 34237148
Book value: 406124390.2439025
P/B ratio: 0.017713726421677848
Market cap (USD): 7193976.34195122
Debt to equity: 0.3468960008648077
Current ratio: 1.1268889913426565
Quick ratio: 1.1268889913426565
Effective tax rate (%): 28.186536406655478
Interest coverage ratio: 3.69568674219837
COGS to revenue (%): 14.001111486976273
R&D to revenue (%): 22.703329628376746
SG&A to revenue (%): 21.535664234282127
Free cash flow (dilution-adjusted): 13189024.390243903
Buyback yield (%): 29.258895897475
Retained earnings: 51507317.07317074
Receivables turnover: 5.733125541125542
Capitalized R&D asset: 59372799.11924119
ROCI (R&D-adjusted, %): 7.105464370063077
Rosenberg metric: 3.7665332794643507
FCF margin (%): 6.533006330643213
Revenue growth (%): 92.32542183846249
Rule of 40 score: 98.85842816910571
Financial ratios for CRW.L — annual report dated 2023-06-30
Total revenue: 220275949.3670886
Gross profit: 187901265.8227848
Operating income: 21729113.924050633
Net income: 11686075.949367087
Capital expenditures: 658227.8481012658
Operating cash flow: 124997468.35443038
Depreciation & amortization: 40711392.40506329
Net tangible assets: -156901265.8227848
Owner earnings: 51739240.50632911
Return on net tangible assets (%): -32.97566800051633
Capex to operating income (%): 3.0292438541302578
Buffett classification: The Great
Stock price: 0.16455696202531644
P/E ratio: 0.48210888648180245
Shares outstanding: 34237148
Book value: 414988607.59493667
P/B ratio: 0.013576182478701567
Market cap (USD): 5633961.063291139
Debt to equity: 0.2644269630705129
Current ratio: 0.8946608153620298
Quick ratio: 0.8946608153620298
Effective tax rate (%): 29.44593045471915
Interest coverage ratio: 2.700330344502124
COGS to revenue (%): 14.697330161247688
Free cash flow (dilution-adjusted): 101525316.4556962
Buyback yield (%): 89.73608702184225
Retained earnings: 50487341.772151895
Receivables turnover: 7.1988582302568975
Capitalized R&D asset: 37377169.71544716
ROCI (R&D-adjusted, %): -0.046923160027018886
Rosenberg metric: 0.31164958425616035
FCF margin (%): 46.09005964900183
Revenue growth (%): 9.110737013128007
Rule of 40 score: 55.20079666212984
Financial ratios for CRW.L — annual report dated 2024-06-30
Total revenue: 239579746.83544302
Gross profit: 205311392.40506327
Operating income: 26386075.949367087
Net income: 14813924.05063291
Capital expenditures: 1507594.9367088608
Operating cash flow: 52989873.41772152
Depreciation & amortization: 42256962.025316454
Net tangible assets: -137818987.34177214
Owner earnings: 55563291.1392405
Return on net tangible assets (%): -40.316136557767024
Capex to operating income (%): 5.713600383785081
Buffett classification: The Great
Stock price: 0.28278481012658224
P/E ratio: 0.6535571104161325
Shares outstanding: 34237148
Book value: 415939240.50632906
P/B ratio: 0.02327682616497054
Market cap (USD): 9681745.396455696
Debt to equity: 0.12217887227930077
Current ratio: 0.6266897910070516
Quick ratio: 0.6266897910070516
Effective tax rate (%): 25.68108211087826
Interest coverage ratio: 4.063352826510721
COGS to revenue (%): 14.303527273495787
Free cash flow (dilution-adjusted): 25845569.620253164
Buyback yield (%): 43.77283754121179
Retained earnings: 49798734.17721519
Receivables turnover: 4.1832729201662096
Capitalized R&D asset: 15125268.292682929
ROCI (R&D-adjusted, %): 2.1569357919645658
FCF margin (%): 10.787877507027073
Revenue growth (%): 8.763461251134942
Rule of 40 score: 19.551338758162014
Financial ratios for CRW.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -125173750
Buffett classification: The Gruesome
Stock price: 0.256875
Shares outstanding: 34237148
Book value: 411398750
P/B ratio: 0.021377477186063403
Market cap (USD): 8794667.3925
Debt to equity: 0.109045664334177
Current ratio: 0.7134552247254613
Quick ratio: 0.7134552247254613
Buyback yield (%): 0
Retained earnings: 48086250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRW.L — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2849315068493151
Shares outstanding: 34237148
Market cap (USD): 9755242.169863015
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DE — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 321.49
Shares outstanding: 269937425
Market cap (USD): 86782182763.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DE — annual report dated 2022-10-31
Total revenue: 51282000000
Gross profit: 15730000000
Operating income: 9026000000
Net income: 7131000000
Capital expenditures: 1695000000
Operating cash flow: 4699000000
Depreciation & amortization: 1895000000
Net tangible assets: 14985000000
Owner earnings: 7331000000
Return on net tangible assets (%): 48.922255588922255
Capex to operating income (%): 18.77908265012187
Buffett classification: The Great
Stock price: 376.43
P/E ratio: 14.249410306093115
Shares outstanding: 269937425
Book value: 20357000000
P/B ratio: 4.9915284615979765
Market cap (USD): 101612544892.75
Debt to equity: 2.5642776440536426
Current ratio: 2.1028316435344685
Quick ratio: 1.8226531482757489
Effective tax rate (%): 21.98970088747672
Interest coverage ratio: 8.499058380414313
COGS to revenue (%): 69.32646932646934
R&D to revenue (%): 3.7284037284037286
SG&A to revenue (%): 7.1077571077571085
Free cash flow (dilution-adjusted): 826000000
Buyback yield (%): 3.539917245254079
Retained earnings: 42247000000
Inventory turnover: 4.163485185618925
Receivables turnover: 1.0469987750102083
Capitalized R&D asset: 1912000000
ROCI (R&D-adjusted, %): 16.758588898831313
FCF margin (%): 1.6107016107016106
Rule of 40 score: 1.6107016107016106
Financial ratios for DE — annual report dated 2023-10-31
Total revenue: 60248000000
Gross profit: 22306000000
Operating income: 14591000000
Net income: 10166000000
Capital expenditures: 2487000000
Operating cash flow: 8589000000
Depreciation & amortization: 2004000000
Net tangible assets: 16302000000
Owner earnings: 9683000000
Return on net tangible assets (%): 59.39761992393572
Capex to operating income (%): 17.04475361524227
Buffett classification: The Great
Stock price: 351.84
P/E ratio: 9.342394610662994
Shares outstanding: 269937425
Book value: 21886000000
P/B ratio: 4.339522233939505
Market cap (USD): 94974783612
Debt to equity: 2.9101708854975783
Current ratio: 2.0213064422211637
Quick ratio: 1.8037689905245884
Effective tax rate (%): 22.052384975804593
Interest coverage ratio: 5.948226661231145
COGS to revenue (%): 62.97636436064268
R&D to revenue (%): 3.6133979551188418
SG&A to revenue (%): 7.152104634178729
Free cash flow (dilution-adjusted): 3991000000
Buyback yield (%): 7.597806202412093
Retained earnings: 50931000000
Inventory turnover: 4.616376688161576
Receivables turnover: 1.0254978723404256
Capitalized R&D asset: 3458040000
ROCI (R&D-adjusted, %): 22.081893220249576
Rosenberg metric: 3.4393305439330546
FCF margin (%): 6.624286283362103
Revenue growth (%): 17.483717483717484
Rule of 40 score: 24.108003767079587
Financial ratios for DE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 395.52
Shares outstanding: 269937425
Market cap (USD): 106765650336
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DE — annual report dated 2024-10-31
Total revenue: 50518000000
Gross profit: 19495000000
Operating income: 11427000000
Net income: 7100000000
Capital expenditures: 2873000000
Operating cash flow: 9231000000
Depreciation & amortization: 2118000000
Net tangible assets: 17374000000
Owner earnings: 6345000000
Return on net tangible assets (%): 36.520087487049615
Capex to operating income (%): 25.14220705346985
Buffett classification: The Good
Stock price: 395.52
P/E ratio: 15.037415540281689
Shares outstanding: 269937425
Book value: 22925000000
P/B ratio: 4.657171225125409
Market cap (USD): 106765650336
Debt to equity: 2.8555288985823335
Current ratio: 2.159816462736374
Quick ratio: 1.9596218020022247
Effective tax rate (%): 22.74603519443841
Interest coverage ratio: 3.413082437275986
COGS to revenue (%): 61.40979452868285
R&D to revenue (%): 4.533037729126252
SG&A to revenue (%): 8.92157250880874
Free cash flow (dilution-adjusted): 4221000000
Buyback yield (%): 3.753079747455902
Retained earnings: 56402000000
Inventory turnover: 4.309348520627865
Receivables turnover: 0.8656123095903085
Capitalized R&D asset: 4379550000
ROCI (R&D-adjusted, %): 15.30332127226352
Rosenberg metric: -1.2912264584290307
FCF margin (%): 8.355437665782492
Revenue growth (%): -16.149913690081
Rule of 40 score: -7.794476024298508
Financial ratios for DE — quarterly report dated 2025-01-31
Total revenue: 8262000000
Gross profit: 3225000000
Operating income: 1478000000
Net income: 869000000
Capital expenditures: 358000000
Operating cash flow: -1132000000
Depreciation & amortization: 549000000
Net tangible assets: 17670000000
Owner earnings: 1060000000
Return on net tangible assets (%): 5.998868138087153
Capex to operating income (%): 24.22192151556157
Buffett classification: The Great
Stock price: 467.55
P/E ratio: 36.308758072137515
Shares outstanding: 269937425
Book value: 22564000000
P/B ratio: 5.593389605510991
Market cap (USD): 126209243058.75
Debt to equity: 2.8654050700230456
Current ratio: 2.2496018749436617
Quick ratio: 2.016916558997626
Effective tax rate (%): 3.016759776536313
Interest coverage ratio: 1.7828709288299156
COGS to revenue (%): 60.96586782861293
R&D to revenue (%): 6.366497216170419
SG&A to revenue (%): 11.76470588235294
Free cash flow (dilution-adjusted): -1951000000
Buyback yield (%): 0.34941973290713413
Retained earnings: 56829000000
Inventory turnover: 0.6504390495867769
Receivables turnover: 0.14352969789621806
Capitalized R&D asset: 526000000
ROCI (R&D-adjusted, %): 2.5988668447880543
FCF margin (%): -23.614137012829822
Rule of 40 score: -23.614137012829822
Financial ratios for DE — quarterly report dated 2025-04-30
Total revenue: 12525000000
Gross profit: 4916000000
Operating income: 2883000000
Net income: 1804000000
Capital expenditures: 450000000
Operating cash flow: 1700000000
Depreciation & amortization: 555000000
Net tangible assets: 19229000000
Owner earnings: 1909000000
Return on net tangible assets (%): 9.927713349628165
Capex to operating income (%): 15.608740894901144
Buffett classification: The Great
Stock price: 456.38
P/E ratio: 17.072345069498336
Shares outstanding: 269937425
Book value: 24378000000
P/B ratio: 5.05349257615473
Market cap (USD): 123194042021.5
Debt to equity: 2.7320124702600705
Current ratio: 2.2137012857427942
Quick ratio: 1.9893377426803889
Effective tax rate (%): 23.063756953359007
Interest coverage ratio: 3.677295918367347
COGS to revenue (%): 60.750499001996005
R&D to revenue (%): 4.383233532934132
SG&A to revenue (%): 9.55688622754491
Free cash flow (dilution-adjusted): 656000000
Buyback yield (%): 0.32225584410219693
Retained earnings: 58191000000
Inventory turnover: 0.966836086404066
Receivables turnover: 0.2069666374737677
Capitalized R&D asset: 901420000
ROCI (R&D-adjusted, %): 4.261439916562476
Rosenberg metric: 3.214828897338403
FCF margin (%): 5.2375249500998
Revenue growth (%): 51.59767610748003
Rule of 40 score: 56.83520105757982
Financial ratios for DE — quarterly report dated 2025-07-31
Total revenue: 11783000000
Gross profit: 4213000000
Operating income: 2159000000
Net income: 1289000000
Capital expenditures: 645000000
Operating cash flow: 2896000000
Depreciation & amortization: 564000000
Net tangible assets: 20040000000
Owner earnings: 1208000000
Return on net tangible assets (%): 6.0279441117764465
Capex to operating income (%): 29.87494210282538
Buffett classification: The Good
Stock price: 517.88
P/E ratio: 35.283996380363455
Shares outstanding: 269937425
Book value: 25264000000
P/B ratio: 5.533375303158644
Market cap (USD): 139795193659
Debt to equity: 2.6492637745408487
Current ratio: 2.314065908153039
Quick ratio: 2.086718151270412
Effective tax rate (%): 21.1875
Interest coverage ratio: 2.7191435768261965
COGS to revenue (%): 64.24509887125521
R&D to revenue (%): 4.718662479843843
SG&A to revenue (%): 10.328439276924382
Free cash flow (dilution-adjusted): 1794000000
Buyback yield (%): 0.21316898828933006
Retained earnings: 59023000000
Inventory turnover: 0.9814598729417866
Receivables turnover: 0.19377703224957654
Capitalized R&D asset: 1097410000
ROCI (R&D-adjusted, %): 2.895558571429016
Rosenberg metric: -1.2805100182149363
FCF margin (%): 15.225324620215563
Revenue growth (%): -5.924151696606787
Rule of 40 score: 9.301172923608776